Skip to content

Precision Allergy: Separate Allergies to Male and Female Dogs

Precision Allergy: Separate Allergies to Male and Female Dogs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03097094
Enrollment
22
Registered
2017-03-31
Start date
2017-03-24
Completion date
2019-01-09
Last updated
2022-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy; Dander

Keywords

Dog allergy, Can f 5, Male dog, Female dog, Allergen components

Brief summary

A new male-specific dog-allergen-component has been found (Can f 5) which indicates possible differences in allergic reactions to male and female dogs. This has not yet been tested in real life. The aim is to test if sensitization only to the male-dog specific allergen-component, Can f 5, results in a positive skin prick test (SPT) to male dog extract and not female dog extract. In addition, the investigators want to investigate if allergic symptoms only occur when exposed to the male dog extract by conjunctival provocation.

Interventions

DIAGNOSTIC_TESTMale dog

Male dog extract

DIAGNOSTIC_TESTFemale dog

Female dog extract

Sponsors

Copenhagen Studies on Asthma in Childhood
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants in the COPSAC 2000 cohort * Positive component test (\>0.3 ISU) to Can f 1, Can f 2, Can f 3 or Can f 5

Exclusion criteria

* Uncontrolled asthma * Eye-surgery within the past 6 months * Antihistamine allergy * and others

Design outcomes

Primary

MeasureTime frameDescription
Male vs. female dog SPT in Can f 5 mono sensitized patients6 monthsIn the patients that have a positive SPT (\> 2mm) to dog and are monosensitized to the Can f 5 component, the investigatiors want to compare the reaction to SPT (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.

Secondary

MeasureTime frameDescription
Male vs. female dog conjunctival provocation in Can f 5 mono sensitized patients6 monthsIn the patients that have a positive SPT (\> 2mm) to dog and are monosensitized to the Can f 5 component, the investigatiors want to compare the reaction to conjunctival provocation (positive/negative) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.
Male vs. female dog conjunctival provocation in dog poly sensitized patients6 monthsIn the patients that have a positive SPT (\> 2mm) to dog and are sensitized to the Can f 1, 2 and/or 3 component, the investigatiors want to compare the reaction to conjunctival provocation (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.
Male vs. female dog SPT in dog poly sensitized patients6 monthsIn the patients that have a positive SPT (\> 2mm) to dog and are sensitized to the Can f 1, 2 and/or 3 component, the investigatiors want to compare the reaction to SPT (pos/neg) to male vs. female dog extract in the same patient using logistic regression analysis with mixed effects to account for repeated measures.
Can f 5 vs. conjunctival provocation6 monthsTo investigate the correlation between sIgE level to the Can f 5 component and the threshold of reaction to the male dog extract at the conjunctival provocation, using a general linear model.
SPT vs. conjunctival provocation6 monthsTo investigate the correlation between SPT wheal size to the male dog extract and the threshold of reaction to the male dog extract at the conjunctival provocation, using a general linear model.
Can f 5 vs. SPT size6 monthsTo investigate the correlation between specific Immunoglobulin E (sIgE) level to the Can f 5 component and the SPT wheal size to the male dog extract using a general linear model.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026